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The neural crest is a unique cell population induced at the lateral border of the neural plate. Neural crest is not produced
at the anterior border of the neural plate, which is fated to become forebrain. Here, the roles of BMPs, FGFs, Wnts, and
retinoic acid signaling in neural crest induction were analyzed by using an assay developed for investigating the
posteriorization of the neural plate. Using specific markers for the anterior neural plate border and the neural crest, the
posterior end of early neurula embryos was shown to be able to transform the anterior neural plate border into neural crest
cells. In addition, tissue expressing anterior neural plate markers, induced by an intermediate level of BMP activity, was
transformed into neural crest by posteriorizing signals. This transformation was mimicked by bFGF, Wnt-8, or retinoic acid
treatment and was also inhibited by expression of the dominant negative forms of the FGF receptor, the retinoic acid
receptor, and Wnt signaling molecules. The transformation of the anterior neural plate border into neural crest cells was also
achieved in whole embryos, by retinoic acid treatment or by use of a constitutively active form of the retinoic acid receptor.
By analyzing the expression of mesodermal markers and various graft experiments, the expression of the mutant retinoic
acid receptor was shown to directly affect the ectoderm. We thereby propose a two-step model for neural crest induction.
Initially, BMP levels intermediate to those required for neural plate and epidermal specification induce neural folds with an
anterior character along the entire neural plate border. Subsequently, the most posterior region of this anterior neural plate
border is transformed into the neural crest by the posteriorizing activity of FGFs, Wnts, and retinoic acid signals. We discuss
a unifying model where lateralizing and posteriorizing signals are presented as two stages of the same inductive process
required for neural crest induction. © 2001 Elsevier Science
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The neural crest is a unique set of ectodermal-derived
cells that undergo extensive and coordinated movements,
giving rise to numerous and diverse cell types, including
much of the peripheral nervous system, the cranofacial
skeleton, and pigment cells (for reviews on neural crest
development see LaBonne and Bronner-Fraser, 1999; Mayor
et al., 1999; Christiansen et al., 2000; Mayor and Aybar,
2001).
The neural crest originates at the border between the
neural plate and the future epidermis. This border corre-
sponds to the neural folds, which surround the entire neural
plate, but only the medial and posterior portions of the folds
give rise to neural crest cells, while the anterior neural fold
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All rights reserved.differentiates as forebrain. Within the neural folds, pre-
sumptive neural crest cells are distinguishable from epider-
mal and neural plate precursors by virtue of their distinct
patterns of gene expression. For example, the zinc finger
and helix–loop–helix transcription factors Xsnail, Xslug,
and Xtwist provide early markers for the region from which
neural crest cells arise in frogs, fish, and chicks (Thiesen
and Bach, 1993; Nieto et al., 1994; Mayor et al., 1995;
Linker et al., 2000). The Xsnail gene is expressed initially at
the midgastrula stage, in an arc above the dorsal marginal
zone which can be precisely identified as a distinct band of
cells surrounding the prospective neural plate cells (Mayor
et al., 1993; Essex et al., 1993). At the end of gastrulation,
the anterior transverse neural fold ceases to express Xsnail,
which is then expressed exclusively in the medial and
posterior portions of the neural folds, regions subsequently
fated to become neural crest. On the other hand, the
expression of Xslug and Xtwist begins at the end of gastru-
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fold. Consequently, this region does not form part of the
neural crest but does contribute to the structure of the
forebrain (Mayor et al., 1995; Hopwood et al., 1989). The
loss of Xsnail expression in the anterior transverse neural
fold is a consequence of gene down-regulation rather than
cell movement (Linker et al., 2000). Taken together, these
observations suggest that these neural fold marker genes are
initially activated along the entire neural plate border, later
becoming restricted to the medioposterior portion of the
neural fold, which then generates prospective neural crest
cells. It should be mentioned that Xsnail, Xtwist, and Xslug
are not specific markers for the neural crest as they are also
expressed in mesoderm (Linker et al., 2000; Mayor et al.,
2000).
Several, but not necessarily substitutive, hypotheses have
been proposed to explain how the neural crest is induced.
Pioneering studies in Urodeles first suggested that the
induction of the neural crest could be mediated by under-
lying tissue, independent from the neural plate (Raven and
Kloos, 1945). More recent experiments show that the dor-
solateral mesoderm, which underlies the prospective neural
crest at the midgastrula stage, is able to induce neural crest
markers in competent ectoderm, whereas Xenopus em-
bryos, from which presumptive nonaxial mesoderm has
been removed, fail to express neural crest markers (Bonstein
et al., 1998; Marchant et al., 1998).
Several experiments also favor a second hypothesis which
proposes that neural crest formation requires interactions
between the neural plate and the epidermis (Moury and
Jacobson, 1989, 1990; Dickinson et al., 1995; Selleck and
Bronner-Fraser, 1995; Mayor et al., 1995; Mancilla and
Mayor, 1996). More recently, it has been suggested that
levels of BMP signaling, intermediate to those that specify
neural plate and epidermis, may play a role in determining
the fate of the neural plate border as well as the neural crest
(Wilson et al., 1997; Marchant et al., 1998). There is also
evidence that this may be true in zebrafish (Neave et al.,
1997; Nguyen et al., 1998). To date, it has been assumed
that this BMP activity gradient is generated through the
interaction of BMPs produced by the ectoderm and BMP-
binding molecules produced by the Organizer (reviewed in
Weinstein and Hemmati-Brivanlou, 1999). Consequently,
this gradient should generate a maximum of BMP activity
in the ventral ectoderm and a minimum in the most dorsal
ectoderm, or dorsal midline, and should specify neural crest
at an intermediate concentration. Although such a gradient
could explain why the neural crest is induced at the border
of the neural plate, this hypothesis does not account for the
anterior–posterior localization of the crest. Indeed, the
neural crest is not induced in the most anterior neural fold.
The anterior–posterior pattern of the neural plate has
been the subject of many studies. Two models have been
proposed to explain the specification of this anterior–
posterior axis (reviewed in Slack and Tannahill, 1992;
Gamse and Sive, 2000). The qualitative model proposes that
the different anterior–posterior positions are determined by
© 2001 Elsevier Science. Adifferent signals arising from corresponding regions of the
underlying mesoderm. On the other hand, the activation/
transformation model (Nieuwkoop and Albers, 1990) sug-
gests that two inducer factors act sequentially during gas-
trulation to induce the anterior–posterior specification.
Initially, the dorsal ectoderm would receive a signal from
the Organizer, determining the induction of the anterior
neural plate. Subsequently, a posteriorizing factor would
convert part of the previously induced anterior neural tissue
to more posterior neural fates (transformation). Several
lines of evidence favor this second model (Sive et al., 1989;
Holowacz and Sokol, 1999; Blumberg et al., 1997; Papa-
lopulu and Kinter, 1996; McGrew et al., 1995). Much of the
evidence that supports this model has come from the
identification of neural inducers and molecules able to
transform neuralized tissue. Several neural-inducing pro-
teins, such as Noggin, Chordin, Follistatin, Xnr3, Cerberus,
and Gremlin, bind to BMPs and induce the anterior neural
plate (reviewed in Harland and Gerhart, 1997), functions
which could correspond to the “activator” signal described
in the activation/transformation model.
Various molecules have been proposed as putative media-
tors of the transformation phase. For instance, four mem-
bers of the fibroblast growth factor (FGF) family, namely
eFGF, FGF3, FGF8, and FGF9, expressed in the posterior
dorsal, lateral, and ventral mesoderm of Xenopus embryos,
are known to be involved in the posteriorization of the
neural plate (Isaac, 1997; Holowacz and Sokol, 1999). Reti-
noic acid also appears to confer posterior positional infor-
mation. Tissue culture experiments have suggested that
retinoic acid acts in a graded manner to induce different
anterior–posterior levels (Simeone et al., 1990).
Similarly, Wnt signaling induces posterior markers in
Xenopus embryos during gastrulation (Wodarz and Nusse,
1998), at which stage, Xwnt3a and Xwnt8 are expressed in
the posterior dorsal, lateral, and ventral mesoderm. Wnt3a
can induce the expression of posterior marker genes in
neuralized ectoderm (McGrew et al., 1995). Conversely, a
truncated Xwnt8 that blocks Wnt signaling prevents the
induction of posterior markers in neuralized ectoderm
(Bang et al., 1999). In summary, there is strong evidence to
support a role for FGFs, Wnts, and retinoic acid in the
posteriorization of the neural plate. However, whether the
neural crest is also posteriorized via a similar cellular or
molecular mechanism has yet to be determined.
In this study, we show for the first time that the anterior
neural fold, which does not express neural crest markers,
can be transformed into a neural crest fate by the addition of
posteriorizing signals. In order to study the anterior–
posterior pattern of the neural plate border, a novel assay
was employed. Pieces of anterior neural fold were dissected
from late-gastrula embryos and either conjugated with the
most posterior region of gastrula embryos or treated with
FGF, Xwnt8, or retinoic acid. Under these conditions, the
expression of anterior neural markers was inhibited and the
induction of neural crest markers was observed. In addition,
weakly neuralized animal caps, which expressed only ante-
ll rights reserved.
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negative form of the BMP4 receptor, were also transformed
to express neural crest markers by conjugating with the
posterior region of a late-gastrula embryo or by treating
with posteriorizing molecules. Finally, the use of dominant
negative mutants of the FGF receptor, a retinoic acid
receptor (RAR), and a Wnt signaling molecule showed that
each of these signals was required for the specification of
neural crest cells. In this paper, we discuss a model whereby
the mediolateral position of the neural crest is specified by
a BMP signaling gradient, while the anterior–posterior pat-
tern is specified by FGF, retinoic acid, and Wnt signaling.
MATERIAL AND METHODS
Embryos and Micromanipulations
Xenopus embryos were obtained by artificial fertilization, dejel-
lied in 2% cysteine (Smith and Slack, 1983), reared in 10% normal
amphibian medium (NAM; Slack, 1984), and staged according to
Nieuwkoop and Faber (1967). Explants, conjugates, and dissections
were carried out by using eyebrow knives, as described in Mancilla
and Mayor (1996).
RNA and RLDx Injection
Dejellied one- or two-cell embryos were placed in 75% NAM
with 5% Ficoll, injected with either differing amounts of RNA, as
indicated, or with 10 nl of 25 mg/ml rhodamine dextran (RLDx,
Molecular Probes), and subsequently reared at 14–16°C. Fluores-
cence was viewed and photographed by using epifluorescence
optics (Zeiss).
Capped RNAs were synthesized from linearized plasmids by
using an appropriate RNA polymerase (Boehringer Mannheim) in
the presence of 500 mM 59-mGpppG-39 cap analog. Injected RNAs
were as follows: DBMPR, a dominant negative of the type II BMP
receptor (Sasai et al., 1995); Xwnt-8 (Christian et al., 1991);
RARa1405, a dominant negative of RARa1 (Blumberg et al., 1997);
XFD, a dominant negative of FGF-1 receptor (Amaya et al., 1991);
dnTCF-3, a dominant negative of TCF-3 (Molenaar et al., 1996);
VP16-xRARa1, a constitutively active form of RARa1 (Blumberg et
al., 1997); and b-galactosidase (b-gal) used as a lineage tracer.
Treatment with FGF and Retinoic Acid
Embryos or animal caps taken from stage 9.5 embryos or the
anterior neural fold taken from stage 12.5 embryos were incubated
with 0.1 ng/ml bFGF (Gibco) or several concentrations (1025 to 1028
M) of all-trans-retinoic acid for 9–12 h, washed, and analyzed as
described under Results. It should be mentioned that the minimal
retinoic acid concentration able to induce neural crest in animal
caps varied between retinoic acid batches.
Whole-Mount in Situ Hybridization
and b-Gal Staining
Antisense RNA probes were prepared for Xslug (neural crest
marker; Mayor et al., 1995); Xag (anterior neural fold marker; Blitz
and Cho, 1995); Xbra (mesodermal marker; Smith et al., 1991);
© 2001 Elsevier Science. Acpl-1 (anterior neural fold marker; Richter et al., 1998); goosecoid
(anterior mesodermal marker; Blumberg et al., 1991); and Xsox-2
(pan neural plate marker; Dr. R. M. Grainger, personal communi-
cation). Specimens were prepared, hybridized, and stained by the
method of Harland (1991) with the modifications described by
Mancilla and Mayor (1996). Double in situ hybridization was
performed as described by Lamb and Harland (1995), using the
following alkaline phosphatase substrates: NBT/BCIP (Boehringer
Mannheim), which produces a purple color; and BCIP, which
produces a green color. b-Gal staining was developed by using
X-gal, as described in Whiting et al. (1991).
RESULTS
Posteriorizing Signals Induce Neural Crest Cells
Previous studies have indicated that the induction of the
neural crest occurs when a threshold concentration of
BMP4 is reached in the ectoderm of Xenopus or zebrafish
embryos (Marchant et al., 1998; Nguyen et al., 1998). Our
own work in animal caps has shown that the expression of
an intermediate level of DBMPR, a dominant negative form
of the BMP receptor, induces the activation of neural crest
markers, while neural plate markers are activated at higher
levels of the same mutant receptor (Figs. 1A and 1B;
Marchant et al., 1998). However, neural crest markers were
usually found to be expressed in larger animal caps but not
so in smaller ones. Whether the size of the animal caps was
important in determining the expression of neural crest
markers was therefore investigated. Embryos were injected
at the one-cell stage with 35 pg of DBMPR mRNA, the
threshold concentration found to induce neural crest mark-
ers in the absence of neural plate markers. Both large and
small animal caps were dissected at stage 9.5 and cultured
to the equivalent of stage 17 for the analysis of neural crest
(Xslug) and neural plate (Xsox-2) markers and to stage 11 for
the mesodermal marker Xbra. No mesodermal (0%, n 5 38)
or neural plate markers (Fig. 1E; 0%, n 5 29) were found to
be expressed in either large or small animal caps, confirm-
ing previous results (Marchant et al., 1998). However, Xslug
expression was observed in 85% of large animal cap and 0%
of small animal caps (Fig. 1C; n 5 62). As a control that the
number of cells was not the factor required to induce Xslug
expression in the large animal caps, groups of three or four
small animal caps were conjugated together in order to
make a large animal cap, but no Xslug expression was
detected (Fig. 1D; 0%, n 5 6). These results suggest that, in
order to induce neural crest cells, another factor is present
and active in larger animal caps in addition to the BMP
threshold.
In this context, we postulated that the application of this
additional signal to small animal caps expressing the
DBMPR threshold concentration could achieve the induc-
tion of neural crest markers. Here, we describe the posteri-
orizing signals in the context of the activation/
transformation model; the initial analysis of these signals is
summarized in Fig. 2A. Small animal caps from embryos
injected at the one-cell stage with 35 pg of DBMPR mRNA
ll rights reserved.
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combined with the most posterior fifth of late-gastrula
FIG. 1. Effect of the size of neuralized caps on neural crest indu
signaling specify neural fold (NF) tissue, lower levels specify the ne
of DBMPR mRNA, corresponding to the neural crest threshold co
small animal caps were dissected at stage 9.5 and cultured to the eq
caps expressed Xslug, while no small caps displayed Xslug expres
groups of three or four caps, cultured as in (C); no Xslug expression
expression (0%, n 5 16).
FIG. 2. Posteriorization of nonneuralized ectoderm. (A) Embryos a
caps were dissected at stage 9.5 and either cultured alone (B and C
the one-cell stage with RLDx (E–H). (I–K) The neurula embryo segm
(C, F, J) was analyzed when caps reached the stage 19 equivalent o
Xag (96%, n 5 40) but no Xslug (0%, n 5 42) or Xbra (0%, n 5 26)
(20% of explants expressed Xag, n 5 43) and an induction in the exp
Although conjugates also expressed Xbra (G), the expression was ori
the quenching in the intensity of the fluorescence by the in situ sig
n 5 38) but did express Xbra (100%, n 5 42).embryos, until the caps reached the equivalent of stage 11
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respectively. Gastrula embryos were previously injected
. (A, B) Summary of previous results: intermediate levels of BMP
plate (NP), and higher levels specify the epidermis (E). (C–E) 35 pg
tration, were injected at the one-cell-stage embryo. (C) Large and
lent of stage 17, when Xslug expression was analyzed: 85% of large
(n 5 62). (D) Small animal caps were dissected and conjugated in
bserved (0%; n 5 6). (E) Big animal caps as (C), analyzed for Xsox-2
one-cell stage were injected with 35 pg of DBMPR mRNA. Animal
onjugated with the posterior fifth of stage 13 embryos injected at
were also cultured alone. The expression of Xag (B, E, I) and Xslug
ge 11 for Xbra expression (D, G, K). (B–D) Injected caps expressed
ession was detected. (E, F) In conjugates, a down-regulation of Xag
n of Xslug (83% of explants expressed Xslug; n 5 42) was observed.
ed from the neurula embryo (labeled tissue, dotted area in H). Note
I–J) Posterior pieces did not express Xag (0%, n 5 33) or Xslug (0%,ction
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As expected, isolated caps expressed anterior neural plate
markers such as Xag and cpl-1, but not neural crest markers
such as Xslug or mesodermal markers such as Xbra (Figs.
2B–2D). Conversely, the isolated pieces of posterior gastrula
expressed neither Xag nor Xslug, but as expected, expressed
Xbra given their posterior mesoderm content (Fig. 2K).
sected from stage 12.5–embryos, avoiding the inclusion of meso-
derm or epidermal tissue. The tissue was cultured alone (B, C) or
conjugated with the posterior fifth of stage 13 embryos, injected
with RLDx at the one-cell stage (D–G). (H and I) The posterior
pieces of the neurula embryos were also cultured alone. The neural
plate was also conjugated with the posterior fifth of stage 13
embryos (J, K). All explants were cultured to the stage 19 equivalent
when the expression of Xag (B, D, and H), Xslug (C, E–G, I, K), and
Xsox2 (J) was determined. (B, C) The anterior neural fold/plate
expressed Xag (90%, n 5 50) but no expression of Xslug (0%, n 5
36) was detected. (D–G) In the conjugates, Xslug expression was
observed in many cases (85% of Xslug expression, n 5 45), while
that of Xag was down-regulated (12% of conjugates expressed Xag,
n 5 48). Xslug-expressing cells came from the anterior neural
fold/plate (unlabeled tissue; F, G), whereas the posterior neurula
segments expressed neither Xag (H, 0%, n 5 38) nor Xslug (I, 0%,
n 5 40). The conjugates of neural plate and the posterior fifth of a
stage 13 embryo expressed Xsox2 (J, 100%, n 5 25), but no
induction of Xslug expression was observed (K, 0%, n 5 25).
FIG. 4. Posteriorizing molecules involved in neural crest induc-
tion. (A) Embryos at the one-cell stage were injected with 35 pg of
DBMPR mRNA. Animal caps were dissected at stage 9.5 and
cultured in isolation (B) or with 1026 M of retinoic acid (C), 0.1
ng/ml bFGF (D), or conjugated with stage 9.5 animal caps taken
from embryos injected at the one-cell stage with 300 pg of
pCSKAXwnt-8 (E). Animal caps were then cultured to the stage 18
equivalent and the expression of Xslug was determined. (B) No
Xslug expression was detected in injected but untreated animal
caps (0%, n 5 40), whereas Xslug expression was clearly observed
in caps treated with bFGF (C, 50%, n 5 30), retinoic acid (D, 45%,
n 5 22), or Xwnt-8 (E, 70%, n 5 33). No expression of Xsox-2 or
Xbra was observed in the caps. (F) The anterior neural fold was
dissected from stage 12.5–embryos, treated with 1026 M of retinoic
acid (G) or with 0.1 ng/ml of bFGF (H), and cultured until the
equivalent of stage 18, and the expression of Xslug was analyzed.
Expression of Xslug was observed in 57% (G, n 5 7) or 63% (H, n 5
8) of the explants. Arrows indicate Xslug expression.
FIG. 5. Inhibition of posteriorizing signals blocks neural crest
induction in vitro. (A) Embryos at the one-cell stage were coin-
jected with 35 pg of DBMPR mRNA and the dominant negatives for
different posteriorizing signals, as indicated below. Animal caps
were dissected at stage 9.5 and conjugated with the posterior fifth
of stage 13 neurula embryos. Conjugates were cultured until the
animal cap reached the equivalent of stage 19, when the expression
of Xslug was analyzed. (B) Conjugates of control animal caps
injected only with DBMPR mRNA displayed clear Xslug expression
(85%, n 5 32), while Xslug expression was inhibited in conjugate
animal caps taken from embryos coinjected with 3 ng of RARa1405
mRNA (C; 22% of explants expressed Xslug, n 5 28), 0.2 ng of XFD
mRNA (D; 21% of explants expressed Xslug, n 5 31), or 0.5 ng ofFIG. 3. Neural crest markers induced by posteriorization of the
dnTCF-3 mRNA (E; 52% of explants expressed Xslug, n 5 28).
ll rights reserved.
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posterior late gastrula down-regulated the expression of Xag
(Fig. 2E, 20% of the explants expressed Xag) and induced the
expression of Xslug (83% of the explants expressed Xslug,
Fig. 2F). Moreover, expression of Xslug was never observed
in the fluorescent part of the conjugates, indicating that the
cells expressing Xslug originated from the animal cap.
In order to rule out the possibility that the posterior
gastrula sections may induce the formation of mesoderm in
the injected caps, leading to the induction of neural crest
markers via the mesoderm, the following experiments were
performed. First, conjugates expressing Xbra were analyzed
under fluorescence microscope to identify the origin of the
Xbra-expressing cells. No animal caps (nonfluorescent)
were seen to express the mesodermal marker Xbra (Figs. 2G
and 2H, 0%, n 5 42). Second, analysis of Xbra was also
carried out in animal caps conjugated with vegetal cells
taken from stage 8 embryos and cultured until the caps
reached the equivalent of stage 11. No Xbra-expressing cells
were observed in these conjugates (not shown). These
results indicate that animal caps taken at stage 9.5 were not
competent to be responsive to the potential mesodermal
inducers present in the posterior part of the late gastrula.
Thus, the transformation of injected animal caps expressing
anterior neural fold markers into caps expressing neural
crest markers, achieved through the juxtaposition with
posterior gastrula sections, suggests that neural crest induc-
tion is likely to require the presence of posteriorizing
signals.
If the above conclusion is true, it should be possible to
directly transform a segment of anterior neural fold, fated to
become forebrain, into neural crest by conjugating it with
the posteriorizing signal source. This experiment was car-
ried out and is described in Fig. 3A. Sections of anterior
neural fold were dissected from early neurula embryos,
taking care to avoid including mesoderm or ventral epider-
mis in the explants. These pieces were conjugated with
posterior portions of the same stage, embryos previously
injected with RLDx (at the one-cell stage). As a control,
anterior and posterior explants were cultured in isolation.
As expected, anterior explants were found to express Xag
but not Xslug, and posterior explants did not express either
of these markers (Figs. 3B, 3C, 3H, and 3I). However, the
expression of Xag was seen to be down-regulated in the
conjugates (Fig. 3D; 12% of the explants expressed Xag n 5
48), whereas a clear induction of Xslug was observed (Fig.
3E; 85% of Xslug n 5 45). In order to determine the origin
of the tissue expressing the neural crest marker, conjugates
were examined under a fluorescence microscope. The
Xslug-expressing cells were seen to originate from the
anterior neural fold (unlabeled tissue). These findings show
that the neural crest can be induced by posteriorization of
the anterior neural fold. In order to analyze whether the
induction of neural crest markers by the posterior region of
a neurula was a specific transformation of the neural fold or
was simply an effect of posteriorization of neural plate,
which in turn expressed the neural crest markers, an
© 2001 Elsevier Science. Aadditional experiment was carried out. The posterior part of
a neurula embryo was conjugated with the anterior neural
fold or with the neural plate, and the expression of Xslug
and Xsox-2 was analyzed (Figs. 3J and 3K). As it was
described before when anterior neural fold was used, expres-
sion of Xslug was observed; however, when neural plate was
used in the conjugates, no Xslug expression was observed
(Fig. 3K), although these conjugates expressed Xsox-2
(Fig. 3J).
Posteriorizing Molecules Induce Neural Crest Cells
As mentioned earlier, the involvement of three signaling
molecules has been described in the posteriorization of the
neural plate: FGF, Wnts, and retinoic acid. As the posteri-
orization of the anterior neural fold was found to contribute
to the induction of the neural crest, the dependency of this
process on the same signals that posteriorize the neural
plate was subsequently analyzed.
Embryos were injected at the one-cell stage with 35 pg of
DBMPR mRNA, and small animal caps were dissected at
stage 9.5 and either cultured in 38% NAM or 38% NAM
containing 0.1 ng/ml bFGF or 1026 M retinoic acid or
conjugated with caps taken from embryos injected with 300
pg pCSKAXwnt-8 DNA (Fig. 4A). The caps and conjugates
were cultured to a stage 10 or 19 equivalent, after which the
expression of Xslug, Xbra, and Xsox-2 was determined. No
Xbra or Xsox-2 expression was detected, indicating the
absence of mesodermal contamination in the cap explants
and that the amount of DBMPR mRNA injected was insuf-
ficient to cause cap neuralization. Xslug expression was not
detected in injected caps cultured alone (Fig. 4B). However,
injected caps treated with FGF, retinoic acid, or Xwnt-8
showed a clear expression of Xslug (Figs. 4C–4E). An
equivalent experiment, in which the segment of anterior
neural fold described in Fig. 3A was treated with either FGF
or retinoic acid, produced a similar expression of the neural
crest marker Xslug (Figs. 4F–4H). These results show that
any of these posteriorizing signals alone, under the present
experimental conditions, is sufficient to induce neural crest
in a tissue otherwise fated to become the anterior border of
the neural plate.
As shown in Fig. 5A, the posteriorizing assay was then
used to analyze whether a lack of these signals inhibited the
induction of neural crest cells. Embryos were injected at the
one-cell stage with either 35 pg DBMPR mRNA or the
dominant negative forms of the FGF-1 receptor or the
retinoic acid receptor, XFD (Amaya et al., 1991) and
RARa1405 (Blumberg et al., 1997), respectively, or with the
dominant negative form of TCF3 (dnTCF3), a component of
the Wnt signaling pathway (for a review, see Barker and
Clevers, 2000). At the late blastula stage, animal caps were
dissected and conjugated with the posterior part of early
neurula-stage embryos, as described before. Conjugates
were cultured until the equivalent of stage 19, after which
the expression of Xslug was analyzed. As previously stated,
conjugates containing DBMPR mRNA-injected caps ex-
ll rights reserved.
295Posteriorization of the Neural Crestpressed the neural crest marker Xslug (Fig. 5B, 83% of
explants expressed Xslug; n 5 34), while this expression
was inhibited in animal caps coinjected with either
RARa1405 (Fig. 5C, 22% of explants expressed Xslug; n 5
28), XFD (Fig. 5D, 21% of explants expressed Xslug; n 5 31),
or dnTCF3 (Fig. 5E, 52% of explants expressed Xslug; n 5
28). These results show that no neural crest cells are
induced when each of the posteriorizing signals is inhibited,
suggesting the involvement of all these signals in the
induction process. It is important to note, however, that the
inhibition achieved by blocking the Wnt signaling pathway
was weaker than that observed for the absence of FGF or
retinoic acid signaling; this will be commented on further
under Discussion.
Retinoic Acid Signaling in Neural Crest Induction
Previous studies have proposed FGF and Wnt signals to be
involved in neural crest induction (Mayor et al., 1995, 1997;
Saint-Jeannet et al., 1997; LaBonne and Bronner-Fraser,
1998). However, those signals were not shown to function
as posteriorizing agents and were instead proposed to act in
conjunction with neural inducer molecules. In addition, the
role of retinoic acid in neural crest induction has yet to be
fully investigated. The results described in this study indi-
cate that retinoic acid is not only sufficient but also
necessary for the induction of neural crest cells, as deter-
mined by using the animal cap and posteriorizing assays.
Further experiments using retinoic acid in whole embryos
were therefore carried out.
Early-gastrula embryos treated with varying concentra-
tions of retinoic acid for 3–6 h were cultured until stage 17.
The expression of the anterior neural fold markers cpl-1
(Fig. 6A) and Xslug (Fig. 6D) was then analyzed. Several
expression patterns were observed depending on the reti-
noic acid concentration employed. At 1 mM, the most
frequent outcome was a reduction in the expression of cpl-1
and its localization to the most anterior part of the embryo
(Fig. 6B). On the other hand, Xslug was up-regulated in the
most anterior neural fold (asterisk in Fig. 6E). An anterior
movement in the posterior limit of Xslug expression was
also observed (Fig. 6E), and sometimes this concentration
induced a complete absence of Xslug (white arrow in Fig.
6H). At 10 mM, complete inhibition of cpl-1 expression was
observed (Fig. 6C), while Xslug was either detected at very
low levels or not detected at all (Fig. 6F). These results can
be interpreted to show retinoic acid functioning as a poste-
riorizing signal and determining the outcome of neural
folds as anterior folds or neural crest. However, retinoic
acid is also known to affect mesodermal patterning and the
mesoderm is involved in neural crest induction.
In order to assess this alternative explanation, double in
situ hybridization experiments were performed in treated
embryos, using neural fold and mesodermal markers, to
determine whether the embryos that displayed an affected
pattern in the neural folds also possessed an abnormal
pattern in the mesoderm. These experiments are summa-
© 2001 Elsevier Science. Arized in Figs. 6G–6J. The most extreme phenotype observed
for Xslug was the complete inhibition of its expression (Fig.
6H, 25% of explants expressed Xslug; n 5 48). However,
even in those cases, the position of the mesoderm was not
affected, as shown by the normal localization of gsc in the
same embryos (arrowheads in Figs. 6G and 6H). The same
extreme inhibitory phenotype was obtained for cpl-1 (white
arrow in Fig. 6J), in which case the position of the notochord
was normal, as detected by Xbra expression (arrowhead in
Figs. 6I and 6J). Taken together, these results suggest that
retinoic acid is involved in the transformation of the
anterior neural fold into neural crest cells without signifi-
cant effects on the mesoderm. In order to test this conclu-
sion further, several mutant forms of RARs were used.
Although only the results for RARa are described here,
the dominant negative and constitutively active forms of
both a and g RAR were tested, as no difference was
observed between these two kinds of retinoic acid recep-
tors. One blastomere of two-cell-stage embryos was in-
jected with 1 ng of xRARa1405 mRNA (the dominant nega-
tive form of RARa) together with b-gal mRNA, as a marker
for the injected blastomere. Embryos thus treated exhibited
cpl-1 expression in a more posterior position (Fig. 7A), while
the effect on Xslug expression was more complex. A clear
movement toward the posterior end was observed at the
posterior limit of Xslug expression, whereas no effect was
observed at the anterior limit (Fig. 7C; 35%, n 5 125). In
normal embryos, the posterior border of cpl-1 expression
corresponds with the anterior border of Xslug expression. If
the embryos injected with xRARa1405 showed a posterior
relocation in the expression of cpl-1 but no effect at the
anterior border for the expression of Xslug, an overlapping
in the expression of these genes should be expected; to test
this possibility, double in situ hybridization was performed.
A clear overlap in the expression of these two markers was
observed at the injected side (Fig. 7E). These results show
that inhibition of RAR is able to profoundly modify the
anterior–posterior expression pattern of the neural folds and
that the anterior neural fold and the posterior limit of the
neural crest are repressed by RA activity.
Next, the effect of a constitutively active form of RAR
(VP16-xRARa1) was assessed by injecting 500 pg of VP16-
xRARa1 mRNA into one blastomere of two-cell-stage em-
bryos and analyzing cpl-1 and Xslug expression at the
neurula stage. The injection of VP16-xRARa1 produced an
anterior movement in cpl-1 expression (Fig. 7B, 67%, n 5
89) and sometimes complete inhibition. Upon analysis of
Xslug expression, two phenotypes were most frequent: 75%
of the injected embryos (n 5 167) showed no Xslug expres-
sion in the injected side (Fig. 7D), whereas 16% displayed a
shift toward the anterior fold. Expression of Xslug at the
anterior neural fold was observed more frequently when the
embryos were injected at the one-cell stage (Fig. 7F, 36%,
n 5 58). Thus, the most common phenotypes induced using
VP16-xRARa1, an activated form of the RAR, were similar
to those produced by direct treatment with retinoic acid.
ll rights reserved.
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injection than by retinoic acid application in solution.
As the results shown in Figs. 8G–8J suggest that the
FIG. 6. Effect of retinoic acid treatment on neural fold pattern
concentrations of retinoic acid for 3–6 h, washed in 10% NAM, and
anterior neural fold marker cpl-1 (A–C, arrowheads; I and J, arrows)
the mesodermal markers gsc (G and H, arrowheads) and Xbra (I and
(B, E, H, J) Embryos treated with retinoic acid at 1026 M or (C and F
and Xslug (E, 56%, n 5 88) expression was observed, with up-regu
in E). Some embryos did not express Xslug (H, 75%, n 5 48) or cp
posterior position of gsc expression (arrowhead in H, 75% normal
expression, n 5 53). At 1025 M, the percentage of embryos display
expression (F, 71% with normal expression, n 5 56) was higher. The
arrows and arrowheads indicate marker expression, whereas white
FIG. 7. Effect on neural fold patterning of mutant retinoic acid r
injected with 3 ng of xRARa1405 (A, C, E) or 1 ng of VP16-xRARa1
together with b-gal mRNA as a marker. Embryos were cultured
analyzed. Injection of xRARa1405 produced a posterior movement i
Xslug expression shifted toward a more posterior position, the a
hybridization for Xslug (purple) and cpl-1 (green) was performed t
(arrow). Injection of VP16-xRARa1 produced an anterior shift in th
of Xslug (D; 48%, n 5 49). However, when the injection was perfo
Xslug at the anterior neural fold (arrow in F; 33%, n 5 42). The ant
bars indicating the posterior limits in the expression of the markeretinoic acid effect was not mesoderm-dependent, an addi-
© 2001 Elsevier Science. Ational experiment was performed to rule out this possibil-
ity. Embryos injected at the one-cell stage with 1 ng of
either xRARa1405 or VP16-xRARa1 mRNA were cultured to
Early-gastrula embryos (stage 10.5) were incubated with varying
ured until sibling embryos reached stage 17. The expression of the
neural crest marker Xslug (D–F arrowheads; G and H, arrows), and
rowheads) was then determined. (A, D, G, and I) Control embryos.
025 M. At 1026 M, an anterior movement in cpl-1 (B; 75%, n 5 87)
of Xslug in the most anterior neural fold in some cases (asterisk
, 77%, n 5 53), in which cases no effect was seen on the anterior
ession, n 5 48) or Xbra expression (arrowhead in J, 100% normal
nhibited cpl-1 (C; 18% with normal expression, n 5 35) or Xslug
rior ends of the embryos are shown in an upward orientation. Black
ws and arrowheads indicate inhibited marker expression.
or expression. Single blastomeres of two-cell-stage embryos were
) or injected at the one-cell stage with 0.5 ng of VP16-xRARa1 (F),
age 17 and the expression of cpl-1 (A, B, E) and Xslug (C–F) was
expression of cpl-1 (A, 92%, n 5 67). While the posterior limit of
ior limit was not affected (C; 58%, n 5 76). (E) Double in situ
ess the overlapping expression of these genes in the injected area
ression of cpl-1 (B; 67%, n 5 48) and inhibition in the expression
at the one-cell stage, more embryos showed ectopic expression of
ends of the embryos are shown in an upward orientation, with theing.
cult
, the
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eriorstage 10 and a piece of ectoderm was taken and grafted onto
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297Posteriorization of the Neural Crestnormal embryos (Fig. 8A). Ectoderms taken from embryos
injected with b-gal mRNA were used as controls. When
control ectoderm was grafted onto the prospective neural
crest region, no expression of cpl-1 was observed (Fig. 8B).
However, when the graft contained xRARa1405, clear ex-
FIG. 8. Effect of mutant retinoic acid receptors is not mesoderm-
either VP16-xRARa1 or xRARa1405 and b-gal mRNA and cultured
stage 12 embryos. The arrows and dotted lines indicate the positio
(B) Dorsal view of an embryo with a control graft in the region of
grafted segment (0%, n 5 15). (C) Dorsal view of an embryo grafted
neural crest: cpl-1 expression was observed in the graft; notice the
grafts express Xslug, n 5 40). (D) Anterior view of an embryo with a
of cpl-1 was seen (90%, n 5 20). (E) Anterior view of an embryo gra
where an inhibited expression of cpl-1 was noted. Notice that the r
the grafts express cpl-1; n 5 10).
FIG. 9. Model of neural crest induction. Dotted area in (A) an
molecules. (A) Early-gastrula stage. A gradient of BMP activity is
activities of BMP intermediate to those required for the specificatio
fold (yellow). (B) Early to midgastrula stage. Signals from the latero
transforming the anterior neural plate border into the future neura
into the posterior region of the embryo, where it continues to prod
of these signals is required for the complete specification of the ne
A, anterior; P, posterior.pression of cpl-1 was observed in the graft (Fig. 8C). Given
© 2001 Elsevier Science. Athat VP16-xRARa1 injection exerted an inhibitory effect on
cpl-1 at the anterior neural fold (Fig. 7B), the graft express-
ing this construct was placed in the anterior neural fold.
When control ectoderm was grafted onto that region, nor-
mal expression of cpl-1 was observed (Fig. 8D, 90%, n 5 20).
dent. (A) Embryos were injected at the one-cell stage with 1 ng of
age 10, after which a portion of ectoderm was grafted onto normal
the grafts. The grafts were recognized by the green b-gal staining.
prospective neural crest: No cpl-1 expression was observed in the
a segment containing xRARa1405 in the region of the prospective
lap in the Xslug expression and b-gal staining (arrow; 50% of the
rol graft in the anterior neural fold region, where normal expression
ith VP16-xRARa1-expressing ectoderm in the anterior neural fold,
n of b-gal staining (green) does not shows cpl-1 expression (20% of
represents the Spemann organizer, which secrets BMP-binding
blished in the ectoderm. The neural plate border is specified at
neural plate or epidermis. This tissue is specified as anterior neural
ral mesoderm, such as Wnt8 and eFGF, spread into the ectoderm,
t. (C) Late-gastrula stage. The lateroventral mesoderm has moved
Wnt8, eFGF, and possible retinoic acid (RA). The continued effect
crest cells. An, animal pole; Vg, vegetal pole; D, dorsal; V, ventral;depen
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uralGrafting of VP16-xRARa1-expressing ectoderm, however,
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grafts (Fig. 8E, n 5 10), a result similar to that obtained by
direct injection of VP16xRARa1 mRNA at the two-cell
stage. This experiment shows that the effect of the mutant
RAR forms was localized directly on the neural folds and
was not dependent on a modification of the mesoderm, seen
to be normal in the grafted embryos. Taken together, these
results point to an important role for retinoic acid and its
receptors for the correct anteroposterior specification of the
neural crest cells.
DISCUSSION
Molecules Involved in Neural Crest Induction
The participation of several molecules in the induction of
the neural crest has been previously reported. We have
shown here that FGF, Wnts, and retinoic acid signals are
involved in the induction of these tissues. BMPs have also
been proposed for the dorsal specification of the neural tube
via two different mechanisms. It has been shown that
neural crest markers are induced by adding BMPs to neural
plate explants (Liem et al., 1995). Recently, several inde-
pendent reports have highlighted the importance of particu-
lar concentrations of BMPs in the specification of the neural
plate border. Levels of BMP intermediate to those required
to induce neural plate and epidermis have been shown to
induce the anterior neural plate border (Wilson et al., 1997),
as well as neural crest cells in Xenopus and in Zebrafish
embryos (Morgan and Sargent, 1997; Marchant et al., 1998;
LaBonne and Bronner Fraser, 1998; Nguyen et al., 1998; this
report). Streit and Stern (1999) also showed that the neural
plate border of chick embryos develops by a combination of
signals where BMPs and their inhibitors are involved.
FGF has also been implicated in neural crest induction
(Mayor et al., 1995, 1997; LaBonne and Bronner-Fraser,
1998). Addition of FGF to weakly neuralized animal caps
has been shown to activate the expression of neural crest
markers, whereas the use of a dominant negative form of
the FGF receptor inhibited the induction of the neural crest
in treated embryos. The role of FGF is nonetheless contro-
versial, as it has also been implicated in neural plate
induction (Launay et al., 1996). However, in Xenopus, the
direct participation of FGF as a neural inducer was ruled out
more recently (Holowacz and Sokol, 1999; Ribisi et al.,
2000; Curran and Grainger, 2000). Wnts and some elements
of the Wnt signaling pathway have also been implicated in
neural crest induction (Saint-Jeannet et al., 1997; LaBonne
and Bronner-Fraser, 1998; Chang and Hemmati-Brivanlou,
1998). Based on the timing of Wnt expression, Wnt factors
were suggested to participate in the maintenance of the
neural crest differentiation program, rather than its initial
specification (Saint-Jeannet et al., 1997).
We have reported here that FGF and Wnt signaling
participate in the neural crest induction process, confirm-
ing previous results. Evidence is also presented regarding
the role of retinoic acid in neural crest induction. The latter
© 2001 Elsevier Science. Ais a novel finding, as this molecule has previously only been
proposed to participate in neural crest differentiation (Bara-
nowitz, 1989; Dupe et al., 1999). It has also been shown that
treatment of Xenopus embryos with retinoic acid affects
the development of cranial nerves derived from neural crest
(Papalopulu et al., 1991). Additionally, it has been shown
that, upon retinoic acid treatment, Pax-3, a gene expressed
at the posterior border of the neural plate and within the
neural plate, is induced in neuralized ectoderm (Bang et al.,
1997). However, in the present study, a novel mechanism
for the participation of these molecules in neural crest
induction is explored.
Models for Neural Crest Induction
The model for neural crest induction currently accepted
today relates to the interaction between neural plate and
epidermis (review in LaBonne and Bronner-Fraser, 1999). A
different, but not necessarily substitutive model, is based
on the induction of specific ectodermal tissues via a BMP
gradient (reviewed in Mayor et al., 1999). Two independent
reports have shown the difficulty of inducing neural crest
markers by lowering BMP activity in the ectoderm, point-
ing to the need for an additional signal (Wilson et al., 1997;
LaBonne and Bronner-Fraser, 1998). On the other hand, two
other reports have shown that neural crest induction was
possible under similar conditions (Morgan and Sargent,
1997; Marchant et al., 1998). In the latter case, the level of
neural crest induction was not very high. The present study
provides a possible explanation for this discrepancy, namely
the size of the animal cap employed, as the neural crest is
induced only when large animal caps are dissected from
embryos treated with the anti-BMPs molecules. Conse-
quently, another factor in addition to the BMP threshold
concentration needs to be present in the animal cap for
neural crest markers to be expressed.
LaBonne and Bronner-Fraser (1998) analyzed an addi-
tional signal required for neural crest induction. These
authors concluded that FGF and Wnt signals could induce
the neural crest in weakly neuralized animal caps, and
proposed a function for these molecules in what they
named a “lateralization” process. We confirmed the partici-
pation of FGFs and Wnts signals on neural crest induction
and added retinoic acid as another additional signal. We
found that all these signals can work as posteriorizing
signals based on an assay developed by Cox and Hemmati-
Brivanlou (1995). Our results show that the anterior neural
plate border, which expresses Xag, can be transformed by
posteriorizing signals into a tissue that expressed neural
crest markers. In addition, anterior neural plate markers,
induced by an intermediate level of BMP activity, could
also be transformed into neural crest by posteriorizing
signals. Our evidence therefore indicates that the signals
involved in the posteriorization of the neural plate exert a
posteriorizing effect on the neural fold, such as FGF, Wnt-8,
or retinoic acid, were sufficient to transform anterior neural
fold into neural crest cells in weakly neuralized animal
ll rights reserved.
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anterior neural fold treated with either FGF or retinoic acid.
However, blocking any of these signals via dominant nega-
tive forms inhibited the induction of neural crest cells in
the in vitro posteriorizing assay. Although each posterior-
izing signal was able to induce the neural crest, the absence
of a single agent inhibited the induction process. A possible
explanation for this discrepancy could relate to the concen-
trations used in the assay, which are probably much above
the levels reached in a normal embryo. It is possible that, in
order to induce the neural crest, the participation of each
posteriorizing signal must occur in an additive manner, so
that independently or under the inhibition of one of the
signals, these would be too weak to posteriorize the em-
bryo. However, the addition in vitro of sufficiently elevated
concentrations of each agent could rescue the embryo from
the absence of other signals. Alternatively, FGF, retinoic
acid, and Wnts signaling could not act independently. They
could work serially; thus, blocking any of the signals would
inhibit induction, but overexpression of any could hyperac-
tivate the pathway leading to neural crest induction.
The outcomes using dominant negatives in whole em-
bryos are also compatible with a role for these agents as
posteriorizing signals, especially in the case of retinoic acid
as analyzed here. The anterior neural fold was transformed
into neural crest by addition of retinoic acid to the embryos
or by expression of a constitutively active form of its
receptor. Inhibition of retinoic acid signaling in dominant
negative mutants caused the opposite result, whereby the
region of the neural crest expressed markers for the anterior
neural plate border, and the posterior limit of the neural
crest moved to a more posterior position. It is interesting to
note that the region of the neural crest least affected by both
expression of the dominant negative form of RAR and
retinoic acid application was the anterior border. This
observation suggests that the different posteriorizing agents
have different roles in the specification of different
anterior–posterior positions in the neural plate border.
Thus, retinoic acid may be more important in the specifi-
cation of the posterior limit of the neural crest and the
posterior limit of the anterior neural fold, while signals
such as Wnts or FGF could play more prominent roles at the
anterior limit of the neural crest cells. The use of a
dominant negative form of the FGF receptor completely
blocked the expression of neural crest markers, a finding
which is concordant with a different role for FGF and
retinoic acid in the posteriorization process of the neural
plate border (Mayor et al., 1997). A similar inhibitory effect
was also observed for the injection of a dominant negative
mutant of Xwnt-8 in treated embryos (LaBonne and
Bronner-Fraser, 1998).
A remaining question was the spatial localization of the
FGFs, Wnts, and retinoic acid signaling molecules, which
must be present in the right place in order to function as a
posteriorizing agents. At the late-gastrula and early-neurula
stages, several members of the FGF and Wnt families have
been found to be expressed in the posterior region of the
© 2001 Elsevier Science. Aembryo (Isaac, 1997; McGrew et al., 1995; Christansen et
al., 1991). Although it has been difficult to determine the
distribution of retinoic acid in the embryo, RARs and
converting enzymes have been found in the presumptive
hindbrain and the posterior region of the embryo during
Xenopus gastrulation (Kolm and Sive, 1997).
A Model of Neural Crest Induction
We present a unifying model of neural crest induction
based on previous reports and on our observations described
here (Fig. 9). At the early-gastrula stage, a gradient of BMP
activity is established in the ectoderm, which specifies the
neural plate, the neural plate border, and the epidermis at
progressively higher concentrations of BMP (Fig. 9A). The
neural plate border, induced at a precise location within the
mediolateral axis of the ectoderm, has an anterior character
(yellow in Fig. 9A). Later, between early and midgastrula
stage, signals presumably originating from the ventrolateral
mesoderm transform a region of the anterior neural plate
border into prospective neural crest cells (Fig. 9B). A role for
this mesoderm in neural crest induction has been shown
(Bonstein et al., 1998; Marchant et al., 1998). The spread of
these molecules from the mesoderm into the ectoderm (Fig.
9B) consequently locates them only in large animal caps,
explaining why the neural crest was not induced when
small animal caps were used. These signals could corre-
spond to Wnt8 and eFGF, as it is known that they are
expressed in the ventrolateral mesoderm, and could corre-
spond to the lateralizing signals described by LaBonne and
Bronner-Fraser (1998). However, the neural crest is not
specified at this stage, as this does not occur until the end of
gastrulation (Mayor et al., 1995; Mancilla and Mayor, 1996).
Thus, additional signals are required for the final induction
of the neural crest. Finally, as gastrulation proceeds, the
ventrolateral mesoderm becomes localized to the posterior
region of the embryo, where it continues to produce Wnt8,
eFGF, and possibly retinoic acid, as well as other, as yet
unknown, posteriorizing agent that generate an anterior–
posterior gradient of these morphogenes. This gradient
would be required for the final specification of the neural
crest in the most posterior region of the neural plate border
(Fig. 9C). Thus, the lateral–posterior regions of the neural
plate border receive the lateralizing/posteriorizing signals
for an extended period of time, finally specifying them as
neural crest. In contrast, the anterior neural plate border
does not receive such signals or these are inhibited by other
agents produced by the anterior regions of the embryo, such
as cerberus or dkk1, two known Wnts inhibitors (Bouw-
meester et al., 1996; Glinka et al., 1998), and, as a conse-
quence, does not develop as neural crest cells. It is tempting
to speculate that the anterior–posterior differences within
the neural crest could be controlled by a similar mecha-
nism.
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